Trial of Ondansetron as a Parkinson's HAllucinations Treatment
Condition: Parkinson's Hallucinations Intervention: Drug: Ondansetron 8mg or matched placebo Sponsors: University College, London; MODEPHARMA Limited; PARKINSONS UK; PRIMENT; SEALED ENVELOPE; Wasdell Packaging Ltd; Custom Pharmaceuticals Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials